| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | H18SKU3289 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | T-cell surface glycoprotein CD3 epsilon chain inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leukemia, Myeloid, Acute | 3 | D015470 | ClinicalTrials |
| Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 219716-33-3 |
| ChEMBL | CHEMBL2108811 |
| FDA SRS | H18SKU3289 |
CONTENTS